Colistin is a critical last-resort antibiotic for life-threatening multidrug-resistant bacterial infections due to the unavailability of a newer class of beta-lactam-beta-lactamase inhibitors, such as ceftazidime-avibactam and imipenem-relebactam. The gene discussed is LACTB; the disease is bacterial infectious disease.